covid 19 News and Research

RSS

Efficacy of NVX-CoV2373 in the US and Mexican adult population

A new study has described the results of PREVENT-19, a phase 3 trial of NVX-CoV2373 that included all adults in the United States and Mexico.

17 Dec 2021

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Researchers have conducted an investigation to probe the similarity of viral epitopes between bovine coronavirus (BCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Dec 2021

Simulating transmission dynamics of SARS-CoV-2 Omicron variant

Researchers simulated the emergence of Omicron, a novel SARS-CoV-2 VOC, in a general European setting using an individual-based transmission model.

17 Dec 2021

Predicting local surges of COVID-19 hospitalizations in 2022

Researchers have identified simple and easy-to-communicate decision rules to provide early warnings - when a pre-specified threshold of hospital capacity will likely be exceeded within a four or eight week period.

17 Dec 2021

Modeling the potential interaction between COVID-19 outbreaks in susceptible and vaccinated sub-populations

Researchers demonstrated that the combination of infection of remaining susceptible individuals and breakthrough infections of vaccinated individuals promotes infection by invading variants.

17 Dec 2021

Vaccine effectiveness against COVID-19 caused by Omicron and Delta SARS-CoV-2 variants in England

Researchers performed a test-negative case-control study to determine the effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines against the Omicron and Delta variants of SARS-CoV-2.

17 Dec 2021

Effectiveness of COVID-19 vaccines among older male veterans

A new research letter assessed the effectiveness of the mRNA1273 and BNT162b2 vaccines among fully vaccinated male veterans who were 65 years of age or above from July to September 2021.

17 Dec 2021

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

Researchers evaluated primary responses in SARS-CoV-2-naïve vaccinees, as well as secondary responses in the SARS-CoV-2-infected vaccines, and observed a clear set of differences in their clinical symptoms, antibody levels, and cellular and mucosal immune responses.

17 Dec 2021

Identifying protein targets in SARS-CoV-2 via machine learning

A new study provides insight on using an ML-based algorithm to analyze and predict therapeutic targets in emerging pathogens with a range of mutations.

17 Dec 2021

WHO supports Nigeria in responding to the yellow fever outbreak amidst a global pandemic

In early November 2020, positive samples for yellow fever were reported from five Nigerian states. Nigeria is a high-risk country for yellow fever and is a priority country for the global eliminate yellow fever epidemics (EYE) strategy.

17 Dec 2021

As hospitals fill up, paramedics spend more time moving patients, less on emergencies

The night after Thanksgiving, a small ambulance service that covers a huge swath of southwestern Colorado got a call that a patient needed an emergency transfer from the hospital in Gunnison to a larger one with an intensive care unit 65 miles away in Montrose.

17 Dec 2021

‘The charges seem crazy’: Hospitals impose a ‘facility fee’ — for a video visit

When Arielle Harrison's 9-year-old needed to see a pediatric specialist at Yale New Haven Health System in June, a telehealth visit seemed like a great option. Since her son wasn't yet eligible to be vaccinated against covid-19, they could connect with the doctor via video and avoid venturing into a germy medical facility.

17 Dec 2021

Seeking refills: Aging pharmacists leave drugstores vacant in rural America

Ted Billinger Jr. liked to joke that he would work until he died. That turned out to be prophetic.

17 Dec 2021

A Day in the Life of a Nutritionist

In this interview, we spoke to Dr. Marion Nestle, a nutritionist, about her day-to-day roles and responsibilities as well as her career highlights.

17 Dec 2021

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.

17 Dec 2021

Investigating SARS-CoV-2 genomics-informed outbreaks using new bioinformatics tools

Researchers have created a tool designed to make as much use of the overwhelming amount of SARS-CoV-2 data as possible.

17 Dec 2021

Long-term characteristics of long-COVID following hospitalization

A new study demonstrates the urgent need for healthcare services to support this huge and quickly growing patient population, which has a significant burden of symptoms, lower exercise ability, and significant reductions in health-related quality of life after one year.

17 Dec 2021